Radiation Oncologist @MDAndersonNews specializing in #prostatecancer #kidneycancer and #brachytherapy. Tweets are my own.
Houston, TX
- Tweets 1,078
- Following 413
- Followers 2,135
- Likes 4,494
Chad Tang, MD retweeted
With 🧡 to our #IKCSNA26 planning committee @LauraBukavinaMD @QingZhangLab @bergsa83 @mkbupathi @ADESAIONCMD @AmyLuckenbaugh @virajmaster @spsutkaMD @ChadTangMD @MVossMD
and 🫶 @salvolarosa @OncoAlert @GEVaughan1 @eric_facs @TiansterZhang @drulkav @jferrell512 @Daniel_J_George
2
9
293
Always great chatting with @AlexSherryMD and @JCO_ASCO on the EXTEND trial.
Hear the latest on MDT for oligomets from the first author himself, @AlexSherryMD!
Check out the paper📜 AND the podcast🎙️ for some main highlights! ☢️
📜ascopubs.org/doi/10.1200/JCO…
🎙️ascopubs.org/do/jco-article-…
@ChadTangMD @ebludmir
2
15
1,092
Chad Tang, MD retweeted
🚨📣 big news at #ESMO26: 🧵1/MASTERPLAN RCT shows adding SABR to perioperative chemotherapy for high-risk localized #pancreatic cancer ⬆️⬆️ median overall survival to 22.0 months vs 14.0 months (HR 0.45). #PancreaticCancer #RadOnc @TROGfightcancer in press @TheLancetOncol - thelancet.com/journals/lanon…
5
84
164
9,043
A benefit of working with @PavlosMsaouel is that we treat many variant RCCs. Renal Medullary Carcinoma is one such variant (0.5% of RCC), which has remarkably different RT sensitivity. MDT to 30gy/5 often achieves a CR and with minimal toxicity even with high dose chemo.
1/5 New in @EurUrolOncol: the largest series yet of metastasis-directed radiation therapy in SMARCB1-deficient #RenalMedullaryCarcinoma. Key finding that this cancer appears far more radiosensitive than clear cell kidney cancer: authors.elsevier.com/c/1n~As… #endRMC #MsaouelLab
2
9
29
2,090
Always a pleasure chatting with @OncoAlert about radiation in #kidneycancer
🩺 The evolving role of SBRT in metastatic kidney cancer
At the 2nd Florence International Consensus, Prof. Chad Tang from @UTMDAnderson highlights how stereotactic body radiotherapy (SBRT) is becoming an increasingly important part of metastatic renal cell carcinoma (RCC) management. #FlorenceConsensus26
🎯 Oligometastatic disease SBRT may help defer systemic therapy and its associated side effects in selected patients. Local treatment approaches—including radiotherapy, surgery and interventional ablation—offer options that work through mechanisms distinct from systemic therapy.
🔬 Oligoprogressive disease By targeting a limited number of progressing lesions, SBRT may allow patients to remain on their current systemic treatment for longer, potentially delaying the need to switch to subsequent lines of therapy.
💡 The key takeaway: Across the metastatic disease spectrum, SBRT is expanding the role of local treatment in kidney cancer care, supporting more tailored treatment strategies and helping clinicians consider how best to manage disease progression while preserving treatment options.
📍 As evidence and clinical experience continue to evolve, multidisciplinary decision-making remains essential to identifying the patients most likely to benefit.
#KidneyCancer
@Lucarecco @CarlottaB @RobClarkeLab @JavierCortesMD @curijoey @delmastro_lucia @ALEDIGNUS12 @Prof_Nadia_H @ClareIsacke @reshmajagsi @KaidarOrit @AnnaKirby17 @matteolambe @Icro_Meattini @hoperugo @TanjaSpanic @MassimoDiMaio75 @Silke_Gillessen @DrRanaMcKay @brian_rini @alison_tree @ChadTangMD @DrYukselUrun @MicheleAquilano @GiulioFrancoli1 @DrDanielHeng
7
45
1,466
Chad Tang, MD retweeted
🩺 The evolving role of SBRT in metastatic kidney cancer
At the 2nd Florence International Consensus, Prof. Chad Tang from @UTMDAnderson highlights how stereotactic body radiotherapy (SBRT) is becoming an increasingly important part of metastatic renal cell carcinoma (RCC) management. #FlorenceConsensus26
🎯 Oligometastatic disease SBRT may help defer systemic therapy and its associated side effects in selected patients. Local treatment approaches—including radiotherapy, surgery and interventional ablation—offer options that work through mechanisms distinct from systemic therapy.
🔬 Oligoprogressive disease By targeting a limited number of progressing lesions, SBRT may allow patients to remain on their current systemic treatment for longer, potentially delaying the need to switch to subsequent lines of therapy.
💡 The key takeaway: Across the metastatic disease spectrum, SBRT is expanding the role of local treatment in kidney cancer care, supporting more tailored treatment strategies and helping clinicians consider how best to manage disease progression while preserving treatment options.
📍 As evidence and clinical experience continue to evolve, multidisciplinary decision-making remains essential to identifying the patients most likely to benefit.
#KidneyCancer
@Lucarecco @CarlottaB @RobClarkeLab @JavierCortesMD @curijoey @delmastro_lucia @ALEDIGNUS12 @Prof_Nadia_H @ClareIsacke @reshmajagsi @KaidarOrit @AnnaKirby17 @matteolambe @Icro_Meattini @hoperugo @TanjaSpanic @MassimoDiMaio75 @Silke_Gillessen @DrRanaMcKay @brian_rini @alison_tree @ChadTangMD @DrYukselUrun @MicheleAquilano @GiulioFrancoli1 @DrDanielHeng
9
17
2,640
Chad Tang, MD retweeted
1/6:
I am excited to share our multi-institutional F-SHARP phase I/II trial, now published in @JCO_ASCO!
doi.org/10.1200/JCO-25-02730
There are limited prospective data defining the optimal management of intraprostatic radiorecurrence (IPR) after definitive RT for prostate cancer.
We asked:
1. Is dose-escalated focal salvage high dose rate brachytherapy safe and effective for IPR?
2. Can Decipher (@Veracyte) identify patients with higher risk of recurrence with salvage ReRT that may benefit from therapeutic intensification?
🧵👇
5
29
56
4,075
Amazing discussion, venue, hosts and friends at the 2nd Annual Florence Consensus meeting. Had a lot of fun and learned a lot!
5
36
1,166
Chad Tang, MD retweeted
Great session of the role of integrating #SBRT and systemic therapy in #mRCC during the amazing #FlorenceConsensus26. Proud of my mentor @DrIacovelli, waiting for #ESMO26 for the results of #PEPEtrial 🔥🔥🔥
Thanks to @GiulioFrancoli1 for inviting us.
@Unicatt #oncologiaGemelli
1
9
20
935
Chad Tang, MD retweeted
The last GU session of 2nd International Florence Consensus is coming to the end, with an amazing discussion about sinergy between RT and systemic treatments in Kidney Cancer!
@ASwaminathMD @DrIacovelli
Chair @ChadTangMD @GiulioFrancoli1
@OncoAlert #FlorenceConsensus26
8
19
676
Chad Tang, MD retweeted
GU consensus results presented by @GiulioFrancoli1 at the International Multidisciplinary Consensus Meeting in Florence.
Different perspectives, shared expertise, and one goal: better care for our patients.
#GUOncology @DrIacovelli @Silke_Gillessen @alison_tree @OncoAlert @BarbaraJereczek @Icro_Meattini @Ric_Campi @ChadTangMD @myESMO @ESTRO_RT @to_be_elizabeth
14
22
990
Chad Tang, MD retweeted
Starting the second Florence multidisciplinary consensus, what a wonderful introduction! @PierluigiBonomo @Icro_Meattini @BarbaraJereczek #FlorenceConsensus26 @OncoAlert @curijoey
9
27
731
Absolute a pleasure hanging out with the international gu rad onc community (+@DrIacovelli). Many thanks to our gracious hosts in Florence.
5
12
61
2,736
Chad Tang, MD retweeted
Wonderful kickoff section warming up for Florence multidisciplinary consensus meeting! #FlorenceConsensus26 #Oncoalert @OncoAlert @ChadTangMD @AlbigesL @piet_ost @PBlanchardMD @DrIacovelli
9
20
801
Chad Tang, MD retweeted
A Great start to #FlorenceOncology26 🇮🇹 with WARMING UP: Exploring New Treatment Strategies and future Advances in Oncology!!
Hope you are here to join us in Florence Italy to experience firsthand some great presentations and discussions in #BreastCancer , #ProstateCancer , #HeanandNeckCancer nd so much more!!
If you could not be here, dont worry, your OncoAlert Network has you covered
As Always, by colleagues...for colleagues
@Icro_Meattini, @PierluigiBonomo, @GiulioFrancoli1, @PBlanchardMD, @piet_ost, @AlbigesL, @fizazi_karim, @ChadTangMD, @EdeAzambuja, @delmastro_lucia, @curijoey, @hoperugo, @BarbaraPistill2 , @E_de_Azambuja @ESTRO_RT @AiroBreast
12
20
2,668
Congrats Vincent!
🌟 Congratulations @VincentWenxinXu who will receive the KCA's Christopher G. Wood Rising Star Award at #IKCSNA26 in November! This award recognizes talented and promising #kidneycancer experts. Read more: kidneycancer.org/2026-ikcsna…
1
11
584
Congrats buddy! Major study that will make waves. @piet_ost @GiulioFrancoli1 @PBlanchardMD @Antoniojconde @fcounago @F_lopez_campos @_ShankarSiva @GiuliaMarvaso84 @drdavidpalma
1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026.
I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch
1
4
21
1,600
Chad Tang, MD retweeted
1/5: I am excited to share that VA STARPORT completed recruitment on Friday October 2, 2026.
I am thankful to the Veterans who participated in the study and to our investigators and research teams across the VA who put in an incredible amount of work to get us here. @VAResearch
7
16
62
6,226
Chad Tang, MD retweeted
I absolutely love the GU oncology community! ❤️❤️
Thank you for organizing @ChadTangMD @ndesai2005
@ASTRO_org #ASTRO26
Amazing company, collaborations, and people. Rousing success for our second IGRT event bringing together gu rad oncs from across the world at #astro26. Always great to see our friends.
Thanks to @pfizer and sumitomo.
2
14
703